Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC.CSBR · Entity 7013 | Director · CEO | March 17, 2023 | March 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHAMPIONS ONCOLOGY, INC.
Report date March 17, 2023 · Filed March 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 858,878 |
Reported balance
After 2023-03-17 transaction · row 1
1 source rowRow 1 · 2023-03-17 · Purchase · Acquired 12,382 · Balance 858,878 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2023 Filed Mar 21, 2023 16:30 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 12,382 | $4.04 | $49,968.80 |
DisclosureSEC source: 0001628280-23-008699 · wf-form4_167941620961163.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 858,878 Read SEC document |
| March 24, 2020 Filed Mar 26, 2020 18:52 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | SaleCommon Stock | 75 | $5.25 | $393.75 |
DisclosureSEC source: 0001628280-20-004085 · wf-form4_158524871650244.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,168 Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 13:54 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 75 | $4.75 | $356.25 |
DisclosureSEC source: 0001628280-20-003966 · wf-form4_158505804986732.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,243 Read SEC document |
| March 11, 2020 Filed Nov 3, 2020 22:38 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionWarrant to purchase shares of Common Stock · Derivative | 2,708 | $4.80 Strike: $4.80 | $12,998.40 |
DisclosureSEC source: 0001628280-20-015394 · wf-form4_160444310667407.xml · derivative · entry 4 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,708 shares Expires 2020-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F1 · shares: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F2 · derivative.exercise_date: The options were immediately exercisable upon grant on March 13, 2015. Read SEC document |
| March 11, 2020 Filed Nov 3, 2020 22:38 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionWarrant to purchase shares of Common Stock · Derivative | 124,232 | $5.76 Strike: $5.76 | $715,576.32 |
DisclosureSEC source: 0001628280-20-015394 · wf-form4_160444310667407.xml · derivative · entry 3 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 124,232 shares Expires 2020-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F1 · shares: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F2 · derivative.exercise_date: The options were immediately exercisable upon grant on March 13, 2015. Read SEC document |
| March 11, 2020 Filed Nov 3, 2020 22:38 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 2,708 | $4.80 | $12,998.40 |
DisclosureSEC source: 0001628280-20-015394 · wf-form4_160444310667407.xml · nonDerivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2020 Filed Nov 3, 2020 22:38 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 124,232 | $5.76 | $715,576.32 |
DisclosureSEC source: 0001628280-20-015394 · wf-form4_160444310667407.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 961,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2019 Filed Jan 16, 2019 20:39 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionWarrant to purchase shares of Common Stock · Derivative | 4,167 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001628280-19-000359 · wf-form4_154767117333530.xml · derivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,940 Underlying: Common Stock · 4,167 shares Expires 2020-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2019 Filed Jan 16, 2019 20:39 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 4,167 | $4.80 | $20,001.60 |
DisclosureSEC source: 0001628280-19-000359 · wf-form4_154767117333530.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 20:18 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 20,000 | $7.44 | $148,800.00 |
DisclosureSEC source: 0001628280-18-015324 · wf-form4_154533707522601.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833,001 Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 18:05 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GiftCommon Stock | 303,581 | $12.34 | $3,746,189.54 |
DisclosureSEC source: 0001628280-18-012548 · wf-form4_153962672199994.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 813,001 F1 · shares: Shares gifted to RA Morris Family Foundation. Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 21:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 2,300 | $3.62 | $8,319.10 |
DisclosureSEC source: 0001628280-18-003737 · wf-form4_152227237995067.xml · nonDerivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,116,582 Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 21:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 2,235 | $3.57 | $7,978.95 |
DisclosureSEC source: 0001628280-18-003737 · wf-form4_152227237995067.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114,282 Read SEC document |
| March 23, 2018 Filed Mar 26, 2018 20:05 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 440 | $3.50 | $1,540.00 |
DisclosureSEC source: 0001628280-18-003566 · wf-form4_152209468717795.xml · nonDerivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111,847 Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 20:05 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 200 | $3.48 | $696.50 |
DisclosureSEC source: 0001628280-18-003566 · wf-form4_152209468717795.xml · nonDerivative · entry 3 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,112,047 Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 20:05 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 60 | $3.50 | $210.00 |
DisclosureSEC source: 0001628280-18-003566 · wf-form4_152209468717795.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111,407 Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 16:07 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 279,177 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001628280-16-020507 · wf-form4_147801643241582.xml · derivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,177 Underlying: Common Stock · 279,177 shares Expires 2026-10-31 F1 · derivative.exercise_date: The Options vest and are exercisable over a twelve month period, with vesting to occur on January 31, 2017, April 30, 2017, July 31, 2017 and October 31, 2017, respectively. Read SEC document |
| October 21, 2016 Filed Oct 24, 2016 18:05 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 10,000 | $1.68 | $16,800.00 |
DisclosureSEC source: 0001628280-16-020189 · wf-form4_147733231914360.xml · nonDerivative · entry 3 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111,347 Read SEC document |
| October 21, 2016 Filed Oct 24, 2016 18:05 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 10,000 | $1.67 | $16,700.00 |
DisclosureSEC source: 0001628280-16-020189 · wf-form4_147733231914360.xml · nonDerivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101,347 Read SEC document |
| October 21, 2016 Filed Oct 24, 2016 18:05 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 10,000 | $1.64 | $16,400.00 |
DisclosureSEC source: 0001628280-16-020189 · wf-form4_147733231914360.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,091,347 Read SEC document |
| October 19, 2016 Filed Oct 20, 2016 20:35 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 10,000 | $1.70 | $17,000.00 |
DisclosureSEC source: 0001628280-16-020147 · wf-form4_147699574297811.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,081,347 Read SEC document |
| October 14, 2016 Filed Oct 17, 2016 13:54 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 10,000 | $1.66 | $16,600.00 |
DisclosureSEC source: 0001628280-16-020090 · wf-form4_147671244818571.xml · nonDerivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,071,347 Read SEC document |
| October 14, 2016 Filed Oct 17, 2016 13:54 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 305 | $1.66 | $506.30 |
DisclosureSEC source: 0001628280-16-020090 · wf-form4_147671244818571.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,347 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 17:09 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 9,695 | $1.66 | $16,093.70 |
DisclosureSEC source: 0001628280-16-020069 · wf-form4_147646494319520.xml · nonDerivative · entry 4 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,042 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 17:09 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,643 | $1.66 | $9,367.38 |
DisclosureSEC source: 0001628280-16-020069 · wf-form4_147646494319520.xml · nonDerivative · entry 3 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051,347 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 17:09 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 4,357 | $1.66 | $7,232.62 |
DisclosureSEC source: 0001628280-16-020069 · wf-form4_147646494319520.xml · nonDerivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,045,704 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 17:09 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 10,000 | $1.68 | $16,800.00 |
DisclosureSEC source: 0001628280-16-020069 · wf-form4_147646494319520.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,041,347 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 14:38 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,000 | $1.66 | $8,300.00 |
DisclosureSEC source: 0001628280-16-020006 · wf-form4_147619669674033.xml · nonDerivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,031,347 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 14:38 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 4,537 | $1.66 | $7,531.42 |
DisclosureSEC source: 0001628280-16-020006 · wf-form4_147619669674033.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,026,347 Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 18:27 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 3,000 | $1.58 | $4,740.00 |
DisclosureSEC source: 0001628280-16-019676 · wf-form4_147448241527792.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,021,810 Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 94,564 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 15 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94,564 shares Expires 2025-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F8 · derivative.exercise_date: Vested as to 70,923 shares on grant; remainder to vest on October 31, 2016. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 90,358 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 14 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,358 shares Expires 2024-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F6 · derivative.exercise_date: Fully Vested. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 16,101 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 13 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,101 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F6 · derivative.exercise_date: Fully Vested. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 112,331 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 12 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,331 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F4 · derivative.exercise_date: Vesting to occur upon completion of performance criteria that have not been set. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 112,331 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 11 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,331 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F7 · derivative.exercise_date: Vested as to 84,249 shares on grant; remainder to vest on November 5, 2016. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 182,580 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 10 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 182,580 shares Expires 2025-10-20 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F4 · derivative.exercise_date: Vesting to occur upon completion of performance criteria that have not been set. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 182,580 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 9 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 182,580 shares Expires 2020-10-25 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F6 · derivative.exercise_date: Fully Vested. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 88,595 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 8 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,595 Underlying: Common Stock · 88,595 shares Expires 2025-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F5 · derivative.exercise_date: Vested as to 66,446 shares on grant; remainder to vest on October 31, 2016. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 83,026 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 7 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,026 Underlying: Common Stock · 83,026 shares Expires 2025-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 14,552 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 6 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,552 Underlying: Common Stock · 14,552 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 101,521 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 5 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,521 Underlying: Common Stock · 101,521 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F4 · derivative.exercise_date: Vesting to occur upon completion of performance criteria that have not been set. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 101,521 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 4 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,521 Underlying: Common Stock · 101,521 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F3 · derivative.exercise_date: Vested as to 74,529 shares on grant; remainder to vest on November 5, 2016. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 150,795 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 3 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,795 Underlying: Common Stock · 150,795 shares Expires 2020-10-25 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 150,795 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · derivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,795 Underlying: Common Stock · 150,795 shares Expires 2020-10-25 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 19:28 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 94,564 | $4.55 | $430,266.20 |
DisclosureSEC source: 0001628280-16-019570 · wf-form4_147388126913678.xml · nonDerivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,737,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 94,564 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 14 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94,564 shares Expires 2025-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F8 · derivative.exercise_date: Vested as to 70,923 shares on grant; remainder to vest on October 31, 2016. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 90,358 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 13 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,358 shares Expires 2024-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F6 · derivative.exercise_date: Fully Vested. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 16,101 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 12 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,101 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F6 · derivative.exercise_date: Fully Vested. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 112,331 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 11 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,331 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F4 · derivative.exercise_date: Vesting to occur upon completion of performance criteria that have not been set. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 112,331 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 10 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,331 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F7 · derivative.exercise_date: Vested as to 84,249 shares on grant; remainder to vest on November 5, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.